Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during each handoff. A shocking 90% to 95% of drug discovery projects reportedly fail — one of the highest fa

Related Stories

Transcript: Here’s what Bill Gates told lawmakers in his recent Epstein testimony

Ex-Redfin CEO Glenn Kelman takes on role at venture firm Greylock

Alibaba's model never trained as an agent — and improved agent performance across seven benchmarks

Xiaomi's HarnessX AI Adapts on the Fly, Boosting Smaller Models' Efficiency